Ugekommentar #110 - Regnskaber fra Ørsted og Novo Nordisk
-
Nøgletal er kongen, ifølge Helge Larsen. Og han har over en længere periode syntes, at Ørsted-aktien var blevet for dyr set på nøgletallene. Anderledes positivt ser det ud for Novo Nordisk, som allerede har nået deres forventninger til 2025. Helge Larsen dykker ned i begge selskaber ovenpå deres seneste regnskaber.
Denne video er ikke en anbefaling om køb eller salg af aktier.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind